Stock Price
P/E Ratio
Volume Traded Today
Dividend
52 Week High/low
Intuitive Surgical Inc Market Cap
The Intuitive Surgical Inc (ISRG) share price is expected to decrease by 1.52% over the next year. This is based on calculating the average 12-month share price estimate provided by 17 stock analysts who have covered ISRG. Price targets range from $410 at the low end to $560 at the high end. The current analyst consensus for ISRG is a buy. Please note analyst price targets are not guaranteed and could be missed completely.
Intuitive Surgical Inc has a total of 17 Wall St Analyst ratings. There are 11 buy ratings, 5 ratings, and 1 sell ratings. Since most analysts have a buy consensus rating, the expectation is that Intuitive Surgical Inc will outperform the market. Investors shouldn't rely purely on analyst ratings; we encourage investors to also take a look at the fundamental and technical analysis in their due diligence.
These are the latest 20 analyst ratings of ISRG.
|
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
|---|---|---|---|---|
| Joanne Wuensch Citigroup | Buy | $560 | Maintains | Aug 22, 2024 |
| Ed Ridley-Day Redburn Atlantic | Buy | $510 | Upgrade | Aug 2, 2024 |
| Matt Miksic Barclays | Overweight | $510 | Maintains | Jul 23, 2024 |
| Mike Polark Baird | Outperform | $503 | Maintains | Jul 19, 2024 |
| Sterling Auty JP Morgan | Overweight | $495 | Maintains | Jul 19, 2024 |
| Richard Newitter Truist Securities | Buy | $520 | Maintains | Jul 19, 2024 |
| Ryan Zimmerman BTIG | Buy | $469 | Maintains | Jul 19, 2024 |
| Adam Maeder Piper Sandler | Overweight | $495 | Maintains | Jul 19, 2024 |
| Cecilia Furlong Morgan Stanley | Equal-Weight | $475 | Maintains | Jul 19, 2024 |
| Rick Wise Stifel | Buy | $475 | Maintains | Jul 19, 2024 |
| Vijay Kumar Evercore ISI Group | In-Line | $410 | Maintains | Jul 19, 2024 |
| Matt Miksic Barclays | Overweight | $490 | Maintains | Jul 18, 2024 |
| Richard Newitter Truist Securities | Buy | $515 | Maintains | Jul 16, 2024 |
| Cecilia Furlong Morgan Stanley | Equal-Weight | $460 | Maintains | Jul 15, 2024 |
| Ryan Zimmerman BTIG | Buy | $459 | Maintains | Jul 15, 2024 |
Citigroup | Buy | Maintains | Jul 11, 2024 | |
| Joanne Wuensch Citigroup | Buy | $512 | Maintains | Jul 10, 2024 |
| Adam Maeder Piper Sandler | Overweight | $490 | Maintains | Jul 9, 2024 |
| Vijay Kumar Evercore ISI Group | In-Line | $425 | Maintains | Jul 2, 2024 |
| David Roman Goldman Sachs | Buy | $500 | Initiates | May 30, 2024 |
When did it IPO
2000
Staff Count
13,676
Country
United States
Sector/Industry
Healthcare/Medical Instruments & Supplies
CEO
Dr. Gary S. Guthart Ph.D.
Market Cap
$171.41B
In 2023, ISRG generated $7.12B in revenue, which was a increase of 14.49% from the previous year. This can be seen as a signal that ISRG's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
Wed, 11 Sep 2024
Sentiment - POSITIVE
Source - Zacks Investment Research
Summary - Intuitive Surgical (ISRG) is gaining attention from Zacks.com users, indicating potential investor interest that could influence the stock's performance.
Why It Matters - Increased attention from Zacks.com users may indicate rising interest or sentiment about Intuitive Surgical, potentially influencing stock performance and investment decisions.
Wed, 11 Sep 2024
Sentiment - NEUTRAL
Source - Zacks Investment Research
Summary - Intuitive Surgical, Inc. (ISRG) closed at $490.93, reflecting a 1.38% increase from the previous day's closing price.
Why It Matters - Intuitive Surgical's stock increase indicates positive market sentiment, potentially attracting more investors and influencing future trading decisions.
Fri, 13 Sep 2024
Sentiment - POSITIVE
Source - Zacks Investment Research
Summary - ISRG, MASI, and VCYT are recommended for investment due to genAI adoption and strong fundamentals, though geopolitical and supply challenges may impact outlook.
Why It Matters - ISRG, MASI, and VCYT show potential for growth due to genAI and strong fundamentals, but geopolitical tensions and supply challenges could impact their performance and stability.
Fri, 13 Sep 2024
Sentiment - POSITIVE
Source - Zacks Investment Research
Summary - Stocks hitting new highs often continue to rise, especially with positive earnings estimate revisions, as seen in three specific companies.
Why It Matters - Stocks reaching new highs often indicate strong momentum, and positive earnings revisions suggest potential for continued growth, making these companies attractive investment opportunities.
Sun, 08 Sep 2024
Sentiment - POSITIVE
Source - 24/7 Wall Street
Summary - Investors are increasingly buying non-technology stocks as they approach the final months of 2024, according to a late August CNBC article.
Why It Matters - Rising interest in non-tech stocks suggests a potential shift in market sentiment, indicating diversification opportunities and changing risk appetites among investors.
Thu, 05 Sep 2024
Sentiment - NEUTRAL
Source - Seeking Alpha
Summary - Intuitive Surgical, Inc. will participate in the Wells Fargo 2024 Healthcare Conference on September 5, 2024, at 9:30 AM ET, with key representatives from the company present.
Why It Matters - Intuitive Surgical's participation in the Wells Fargo Healthcare Conference signals potential insights into its strategy and performance, influencing investor sentiment and stock valuation.
The information that Ticker Nerd provides is general in nature as it has been prepared without taking account of your objectives, financial situation or needs. It is not intended as legal, financial or investment advice and should not be construed or relied on as such. Ticker Nerd is for information purposes only. Ticker Nerd is not responsible for any damages or losses that may occur as a result of reliance on this information. Before making any commitment of a legal or financial nature you should seek advice from a qualified and registered legal practitioner or financial or investment adviser. All content, group, messaging, tweets, newsletter, article, and email created by Ticker Nerd is intended for educational and information purposes only, is not financial, investment, legal or tax advice, and is a restatement, summary or extract of other data and research reports that are widely distributed from sources such as, but not limited to, Bloomberg, Market Watch, Wall Street Journal, Google Finance, and Yahoo Finance. Ticker Nerd is not a registered financial, investment, legal or tax advisor and is not liable for any financial loss you may incur acting on any information provided by Ticker Nerd. By registering, you agree not to hold Ticker Nerd liable at any time or under any circumstances for your decisions, actions, or results.
